Abenes, Arlyn C.
HRN: 00-10-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2023
CEFUROXIME 500MG (TAB)
06/27/2023
07/04/2023
PO
500mg
BID X 7 Days
G1P1 (1001) S/P NSVD; Thinly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes